ORAMED PHARMACEUTICALS INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2010 to Q3 2024.
  • Oramed Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$19.6M, a 509% decline year-over-year.
  • Oramed Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $4.47M.
  • Oramed Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $5.53M.
  • Oramed Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$36.6M, a 59% decline from 2021.
  • Oramed Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$23M, a 99.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.47M -$19.6M -$16.4M -509% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $20.9M $9.21M +$10.4M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $10.5M $1.54M +$4.93M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.53M $13.3M +$21.6M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 -$16.1M -$3.22M +$3.84M +54.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$19.9M -$1.19M +$9.34M +88.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$29.2M -$3.4M +$7.31M +68.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$36.6M -$8.26M +$4M +32.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 -$40.6M -$7.06M -$1.37M -24% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$39.2M -$10.5M -$6.62M -169% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$32.6M -$10.7M -$4.65M -76.6% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$27.9M -$12.3M -$4.93M -67.3% Sep 1, 2021 Dec 31, 2021 10-QT 2022-03-30
Q3 2021 -$23M -$5.69M -$2.7M -90% Jul 1, 2021 Aug 31, 2021 10-K 2021-11-24
Q2 2021 -$20.3M -$3.91M -$1.63M -71.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$18.7M -$6.06M -$2.38M -64.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$16.3M -$7.32M -$4.78M -188% Sep 1, 2020 Dec 31, 2020 10-QT 2022-03-30
Q3 2020 -$11.5M -$3M +$14.8M +83.2% Jun 1, 2020 Aug 31, 2020 10-K 2021-11-24
Q2 2020 -$26.3M -$2.28M -$6.36M -156% Mar 1, 2020 May 31, 2020 10-Q 2021-07-14
Q1 2020 -$20M -$3.69M -$7.39M -200% Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-13
Q4 2019 -$12.6M -$2.54M +$1.76M +40.9% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-14
Q3 2019 -$14.4M -$17.8M -$14.9M -509% Jun 1, 2019 Aug 31, 2019 10-K 2020-11-24
Q2 2019 $545K $4.07M +$8.43M Mar 1, 2019 May 31, 2019 10-Q 2020-07-07
Q1 2019 -$7.88M $3.7M +$6.62M Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-06
Q4 2018 -$14.5M -$4.3M -$1.77M -70% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-09
Q3 2018 -$12.7M -$2.93M -$230K -8.53% Jun 1, 2018 Aug 31, 2018 10-K 2019-11-27
Q2 2018 -$12.5M -$4.35M -$2.39M -122% Mar 1, 2018 May 31, 2018 10-Q 2019-07-10
Q1 2018 -$10.1M -$2.92M +$267K +8.39% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-10
Q4 2017 -$10.4M -$2.53M +$105K +3.98% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-14
Q3 2017 -$10.5M -$2.7M +$6.06M +69.2% Jun 1, 2017 Aug 31, 2017 10-K 2019-11-27
Q2 2017 -$16.5M -$1.97M -$3.96M -198% Mar 1, 2017 May 31, 2017 10-Q 2018-07-12
Q1 2017 -$12.6M -$3.18M -$1.37M -75.1% Dec 1, 2016 Feb 28, 2017 10-Q 2018-04-09
Q4 2016 -$11.2M -$2.64M -$246K -10.3% Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-11
Q3 2016 -$11M -$8.75M -$6.64M -314% Jun 1, 2016 Aug 31, 2016 10-K 2018-11-28
Q2 2016 -$4.33M $2M +$3.58M Mar 1, 2016 May 31, 2016 10-Q 2017-07-06
Q1 2016 -$7.91M -$1.82M -$181K -11.1% Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-05
Q4 2015 -$7.73M -$2.39M -$494K -26.1% Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-11
Q3 2015 -$7.23M -$2.12M +$3.17M +60% Jun 1, 2015 Aug 31, 2015 10-K 2017-11-29
Q2 2015 -$10.4M -$1.58M -$3.41M -187% Mar 1, 2015 May 31, 2015 10-Q 2016-07-06
Q1 2015 -$6.99M -$1.64M -$522K -46.8% Dec 1, 2014 Feb 28, 2015 10-Q 2016-04-06
Q4 2014 -$6.47M -$1.9M -$772K -68.7% Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-13
Q3 2014 -$5.7M -$5.29M -$13M -169% Jun 1, 2014 Aug 31, 2014 10-K 2016-11-25
Q2 2014 $7.26M $1.83M +$3.08M Mar 1, 2014 May 31, 2014 10-Q 2015-07-01
Q1 2014 $4.18M -$1.12M +$111K +9.04% Dec 1, 2013 Feb 28, 2014 10-Q 2015-04-03
Q4 2013 $4.07M -$1.12M -$165K -17.2% Sep 1, 2013 Nov 30, 2013 10-Q 2015-01-08
Q3 2013 $4.23M $7.67M +$9M Jun 1, 2013 Aug 31, 2013 10-K 2015-11-25
Q2 2013 -$4.77M -$1.26M -$706K -128% Mar 1, 2013 May 31, 2013 10-Q 2014-07-14
Q1 2013 -$4.06M -$1.23M -$240K -24.4% Dec 1, 2012 Feb 28, 2013 10-Q 2014-04-10
Q4 2012 -$3.82M -$959K -$480K -100% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-14
Q3 2012 -$3.34M -$1.33M -$557K -72% Jun 1, 2012 Aug 31, 2012 10-K 2014-11-14
Q2 2012 -$2.79M -$550K -$1.01M -220% Mar 1, 2012 May 31, 2012 10-Q 2013-07-17
Q1 2012 -$1.78M -$985K -$343K -53.3% Dec 1, 2011 Feb 29, 2012 10-Q 2013-04-11
Q4 2011 -$1.44M -$479K +$124K +20.6% Sep 1, 2011 Nov 30, 2011 10-Q 2012-12-26
Q3 2011 -$1.56M -$773K Jun 1, 2011 Aug 31, 2011 10-Q 2014-04-10
Q2 2011 $457K Mar 1, 2011 May 31, 2011 10-Q 2012-07-12
Q1 2011 -$643K Dec 1, 2010 Feb 28, 2011 10-Q 2012-04-04
Q4 2010 -$603K Sep 1, 2010 Nov 30, 2010 10-Q 2012-01-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.